{"id":31089,"date":"2025-09-02T13:30:13","date_gmt":"2025-09-02T17:30:13","guid":{"rendered":"https:\/\/blueheronhealthnews.com\/site\/?p=31089"},"modified":"2025-08-30T11:19:06","modified_gmt":"2025-08-30T15:19:06","slug":"ms-33-stabilized-40-improved-how","status":"publish","type":"post","link":"https:\/\/blueheronhealthnews.com\/site\/2025\/09\/02\/ms-33-stabilized-40-improved-how\/","title":{"rendered":"MS: 33% stabilized, 40% improved \u2014 how?"},"content":{"rendered":"

\"MS:In multiple sclerosis, your immune system attacks the protective covering of your nerves.<\/p>\n

This leads to inflammation, nerve damage, and, over time, disability.<\/p>\n

But a new review in Cureus<\/em> points to a potential breakthrough: mesenchymal stem cell (MSC) therapy.<\/p>\n

Current MS treatments mostly focus on slowing the disease or reducing inflammation.
\nThey don\u2019t fix the damage already done.<\/p>\n

That\u2019s why MSC therapy is so exciting.
\nThese stem cells, found in bone marrow, fat, and other tissues, can transform into different cell types \u2014 including ones that release healing molecules.
\nThey calm inflammation and may repair nerve tissue.<\/p>\n

Researchers reviewed eight studies involving 157 MS patients.
\nParticipants received MSCs either through spinal canal injections or directly into the bloodstream.
\nThe cells came from various sources \u2014 umbilical cords, modified versions with extra healing factors, and more.<\/p>\n

To measure success, researchers looked at brain scans, clinical outcomes, and spinal fluid biomarkers linked to nerve damage, inflammation, and tissue repair.<\/p>\n

Here\u2019s what they found:<\/p>\n

\n
\n●\tBiomarkers of nerve damage, like neurofilament light chain, dropped<\/p>\n

●\tInflammation markers (CXCL13, CCL2) fell<\/p>\n

●\tRegulatory T cells went up, pro-inflammatory T helper 17 cells went down<\/p>\n

●\tTissue repair markers like MMP9 appeared in spinal fluid<\/p>\n

●\tNatural killer (NK) cell levels decreased<\/p>\n

●\tMRI scans revealed smaller brain lesions\n<\/dd>\n<\/dl>\n

And most importantly\u2026
\nIn the largest trial, disability scores (EDSS) improved for about 40% of patients, stayed stable for 33%, and worsened in just 18%.<\/p>\n

The treatment was safe. Most side effects were minor \u2014 headaches, fever, or mild injection reactions.<\/p>\n

On the other hand, MSC therapy is complicated, expensive, and not widely available.<\/p>\n

But this study proves that MS can be reversed by calming the immune system and repairing nerve tissue.<\/p>\n

And the same thing can be done in a much simpler way \u2014 naturally.<\/p>\n

Thousands of readers have seen similar or better results using the right diet and lifestyle changes explained here\u2026<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

In multiple sclerosis, your immune system attacks the protective covering of your nerves. This leads to inflammation, nerve damage, and, over time, disability. But a new review in Cureus points to a potential breakthrough: mesenchymal stem cell (MSC) therapy. Current MS treatments mostly focus on slowing the disease or reducing inflammation. They don\u2019t fix the […]<\/p>\n","protected":false},"author":8,"featured_media":31163,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[36,169],"tags":[],"class_list":["post-31089","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-multiple-sclerosis"],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/blueheronhealthnews.com\/site\/wp-content\/uploads\/2025\/09\/Multiple-Sclerosis-101666345.jpg","_links":{"self":[{"href":"https:\/\/blueheronhealthnews.com\/site\/wp-json\/wp\/v2\/posts\/31089","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blueheronhealthnews.com\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blueheronhealthnews.com\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blueheronhealthnews.com\/site\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/blueheronhealthnews.com\/site\/wp-json\/wp\/v2\/comments?post=31089"}],"version-history":[{"count":2,"href":"https:\/\/blueheronhealthnews.com\/site\/wp-json\/wp\/v2\/posts\/31089\/revisions"}],"predecessor-version":[{"id":31164,"href":"https:\/\/blueheronhealthnews.com\/site\/wp-json\/wp\/v2\/posts\/31089\/revisions\/31164"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blueheronhealthnews.com\/site\/wp-json\/wp\/v2\/media\/31163"}],"wp:attachment":[{"href":"https:\/\/blueheronhealthnews.com\/site\/wp-json\/wp\/v2\/media?parent=31089"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blueheronhealthnews.com\/site\/wp-json\/wp\/v2\/categories?post=31089"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blueheronhealthnews.com\/site\/wp-json\/wp\/v2\/tags?post=31089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}